Company intelligence / Profile preview

BioCen

Ownership: Private
Development stage: Commercial

Overview

BioCen is a Cuban biopharmaceutical company with commercial manufacturing of active pharmaceutical ingredients such as Granulocyte Colony Stimulating Factor and Recombinant Streptokinase. It also develops immunomodulators, allergenic vaccines, antianemics, food supplements/nutraceuticals, microbiological and plant culture media, and products for Alzheimer’s disease. The company operates under ISO 9001-certified quality management systems and offers contract manufacturing services to other companies. Its facilities are GMP-compliant and certified by Cuban/foreign regulatory authorities

Therapeutic areas: OncologyImmunologyHematologyCardiovascularNeurology
Modalities: Recombinant proteinSmall moleculeVaccineNutraceuticals
Industry: Biotech

Drug pipeline

8 assets

blomia tropicalis allergen extract

7 more assets in the full pipeline.

Request access →

Partnerships

not explicitly listed; provides contract manufacturing services to other companies

Beyond the preview

Go deeper on BioCen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioCen.

Explore the full profile